Terumo Co. (OTCMKTS:TRUMY – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 17,200 shares, a decrease of 47.4% from the December 31st total of 32,700 shares. Based on an average daily trading volume, of 133,300 shares, the short-interest ratio is currently 0.1 days.
Terumo Price Performance
Shares of OTCMKTS:TRUMY traded down $0.12 during midday trading on Wednesday, hitting $19.51. The stock had a trading volume of 57,249 shares, compared to its average volume of 172,047. The company’s 50-day moving average price is $19.61 and its 200-day moving average price is $18.99. Terumo has a fifty-two week low of $14.06 and a fifty-two week high of $21.22. The company has a quick ratio of 1.70, a current ratio of 2.94 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $29.08 billion, a P/E ratio of 40.76 and a beta of 0.65.
Terumo (OTCMKTS:TRUMY – Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.13 earnings per share (EPS) for the quarter. The business had revenue of $1.68 billion during the quarter.
About Terumo
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Read More
- Five stocks we like better than Terumo
- 3 Warren Buffett Stocks to Buy Now
- 3 Steel Stocks Soaring After Tariff Announcements
- Consumer Discretionary Stocks Explained
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.